TY - JOUR
T1 - Tumor microenvironment complexity
T2 - Emerging roles in cancer therapy
AU - Swartz, Melody A.
AU - Iida, Noriho
AU - Roberts, Edward W.
AU - Sangaletti, Sabina
AU - Wong, Melissa H.
AU - Yull, Fiona E.
AU - Coussens, Lisa M.
AU - DeClerck, Yves A.
PY - 2012/5/15
Y1 - 2012/5/15
N2 - The tumor microenvironment (TME) consists of cells, soluble factors, signaling molecules, extracellular matrix, and mechanical cues that can promote neoplastic transformation, support tumor growth and invasion, protect the tumor from host immunity, foster therapeutic resistance, and provide niches for dormant metastases to thrive. An American Association for Cancer Research (AACR) special conference held on November 3-6, 2011, addressed five emerging concepts in our understanding of the TME: its dynamic evolution, how it is educated by tumor cells, pathways of communication between stromal and tumor cells, immunomodulatory roles of the lymphatic system, and contribution of the intestinal microbiota. These discussions raised critical questions on how to include the analysis of the TME in personalized cancer diagnosis and treatment.
AB - The tumor microenvironment (TME) consists of cells, soluble factors, signaling molecules, extracellular matrix, and mechanical cues that can promote neoplastic transformation, support tumor growth and invasion, protect the tumor from host immunity, foster therapeutic resistance, and provide niches for dormant metastases to thrive. An American Association for Cancer Research (AACR) special conference held on November 3-6, 2011, addressed five emerging concepts in our understanding of the TME: its dynamic evolution, how it is educated by tumor cells, pathways of communication between stromal and tumor cells, immunomodulatory roles of the lymphatic system, and contribution of the intestinal microbiota. These discussions raised critical questions on how to include the analysis of the TME in personalized cancer diagnosis and treatment.
UR - http://www.scopus.com/inward/record.url?scp=84861116448&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861116448&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-12-0122
DO - 10.1158/0008-5472.CAN-12-0122
M3 - Article
C2 - 22414581
AN - SCOPUS:84861116448
SN - 0008-5472
VL - 72
SP - 2473
EP - 2480
JO - Cancer Research
JF - Cancer Research
IS - 10
ER -